1-3 of 3
Haruna Shioya
Close
Sort by
Journal Articles

Improved Overall Survival Among Newly Diagnosed Aggressive Adult T-Cell Leukemia/Lymphoma Patients Treated with Mogamulizumab Plus EPOCH Compared to Mogamulizumab Plus Vcap-AMP-Vecp

Tatsuro Jo, MD PhD, Kaori Matsuzaka, Haruna Shioya, Hiroo Tominaga, Takahiro Sakai, Yohei Kaneko, Shizuka Hayashi, Masatoshi Matsuo, MD, PhD, Jun Taguchi, MD PhD, Kazuto Shigematsu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4048.
https://doi.org/10.1182/blood-2019-123984
Published: 2019
Journal Articles

Cytotoxic Immune Response Can be Obtained Earlier in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Dasatinib Than with Other Tyrosine Kinase Inhibitors

Tatsuro Jo, MD PhD, Yohei Kaneko, Kazuhiro Noguchi, Shizuka Hayashi, Risa Hayase, Haruna Shioya, Sadaharu Irie, Kensuke Horio, MD, Jun Taguchi, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3016.
https://doi.org/10.1182/blood-2018-99-113316
Published: 2018
Journal Articles

Dasatinib-Induced Lymphocyte Elevation and Imbalance of T Cell Receptor V Beta Gene Expression in Chronic Phase Chronic Myelogenous Leukemia Patients

Tatsuro Jo, MD PhD, Sadaharu Irie, Kazuhiro Noguchi, Shizuka Hayashi, Risa Hayase, Haruna Shioya, Yohei Kaneko, Kensuke Horio, MD, Jun Taguchi, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1613.
https://doi.org/10.1182/blood.V130.Suppl_1.1613.1613
Published: 2017